Global strategic partnerships in regenerative medicine. Trends Biotechnol. 2014 Sep; 32(9):436-40.

Citation

French A, Suh JY, Suh CY, Rubin L, Barker R, Bure K, Reeve B, Brindley DA. 2014. Global strategic partnerships in regenerative medicine. Trends in biotechnology. 32(9):436-40. Pubmed: 25150363 DOI:S0167-7799(14)00110-3

Abstract

The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine, focusing on agreements involving one or more private entities. A majority of the largest biopharmaceutical companies have announced strategic partnerships with a specific regenerative medicine focus, signifying the growth and widening appeal of this emerging sector.

Related Faculty

Lee Rubin, Ph.D.

Rubin Lab

Lee Rubin investigates the key molecular mediators of a variety of neurodegenerative diseases, with the ultimate goal of finding effective preclinical therapeutic candidates.